Raphin1

CAS No. 2022961-17-5

Raphin1 ( —— )

Catalog No. M21085 CAS No. 2022961-17-5

Raphin1 is an orally bioavailable selective inhibitor of the regulatory phosphatase PPP1R15B (R15B).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 45 Get Quote
5MG 64 Get Quote
10MG 102 Get Quote
25MG 183 Get Quote
50MG 275 Get Quote
100MG 411 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Raphin1
  • Note
    Research use only not for human use.
  • Brief Description
    Raphin1 is an orally bioavailable selective inhibitor of the regulatory phosphatase PPP1R15B (R15B).
  • Description
    Raphin1 is an orally bioavailable selective inhibitor of the regulatory phosphatase PPP1R15B (R15B).
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phosphatase
  • Recptor
    Phosphatase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2022961-17-5
  • Formula Weight
    231.08
  • Molecular Formula
    C8H8Cl2N4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL?(540.94 mM ;?
  • SMILES
    N=C(N)N/N=C/c1cccc(Cl)c1Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Krzyzosiak A Sigurdardottir A Luh Let al.Target-Based Discovery of an Inhibitor of the Regulatory Phosphatase PPP1R15B.Cell. 2018 Aug 23 ;174(5):1216-1228.e19.?
molnova catalog
related products
  • Talabostat mesylate

    Talabostat mesylate is an orally active, selective inhibitor of dipeptidyl peptidases IV (DPP4, IC50: 0.18 nM), including tumor-associated fibroblast activation protein.

  • Razuprotafib

    Razuprotafib (AKB-9778) is a potent and selective inhibitor of the catalytic activity of VE-PTP (vascular endothelial protein tyrosine phosphatase) with an IC50of 17 pM.

  • MP07-66

    MP07-66 is a novel FTY720-analog devoid of immunosuppressive effects leads to the reactivation of PP2A, which in turn triggers apoptosis of CLL cells.